Identifying Clinicopathological Factors Associated with Oncotype DX(®) 21-Gene Recurrence Score: A Real-World Retrospective Cohort Study of Breast Cancer Patients in Quebec City, Canada

Gene expression profiling tests such as the Oncotype DX (ODX) 21-gene recurrence score (RS) assay is increasingly used in clinical practice to predict the risk of recurrence and support treatment planning for early-stage breast cancer (BC). However, this test has some disadvantages such as a high co...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagnet, Simon, Diorio, Caroline, Provencher, Louise, Mbuya-Bienge, Cynthia, Lapointe, Julie, Morin, Claudya, Lemieux, Julie, Nabi, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471231/
https://www.ncbi.nlm.nih.gov/pubmed/34575635
http://dx.doi.org/10.3390/jpm11090858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471231/
https://www.ncbi.nlm.nih.gov/pubmed/34575635
http://dx.doi.org/10.3390/jpm11090858

Ejemplares similares